Comparison of Lasix and Methyldopa in Controlling Hypertension in preeclampsia patients: A Double-Blind Randomized Clinical Trial
Men's Health Journal,
Vol. 4 No. 1 (2020),
19 April 2020
Introduction: Preeclampsia is a specific gestational syndrome that reduces organ perfusion due to vascular spasm and endothelial activation. Despite the use of magnesium sulfate, the patient's blood pressure sometimes remains uncontrolled, and therefore, it is necessary to use other medications, especially diuretics and Methyldopa. Hence, the aim of this study was to compare Lasix and Methyldopa in controlling postpartum hypertension in preeclampsia patients after magnesium sulfate treatment. Material and Methods: This double-blind randomized clinical trial was carried out on 100 women with preeclampsia referred to Akbar Abadi Hospital-Iran. In the first 24 hours after the termination of pregnancy, the participants’ blood pressure was measured and those with a blood pressure of 140/90 to 160/100 were divided into two groups. In the first and second 24 hours, and then one week after the intervention, systolic and diastolic blood pressure as well as diuresis and drug complications in the two groups were assessed and compared. The present study was registered in the Iranian Registry of Clinical Trials (IRCT) under the ID of IRCT20180114038349N1. Results: The mean age of individuals was 29.93 ± 6.65 in the Methyldopa group, and 32.35 ± 4.85 in the Lasix group (P = 0.479). Systolic and diastolic blood pressure had a substantial reduction in both groups, but there was no significant difference between the two groups (P> 0.05). Systolic blood pressure was reduced by 31 mmHg (reduction from 146 to 115) in the methyldopa group and 30 mmHg (reduction from 145 to 114) in the Lasix group. Furthermore, the reduction in diastolic blood pressure was 25 mmHg (from 95 to 70) in the methyldopa group, and 21 mmHg in the Lasix one (from 91 to 70). Conclusion: The present study showed that using Lasix and methyldopa was effective enough in changing blood pressure in patients with preeclampsia, and the effects observed in the two groups were the same. Therefore, it could have a great impact on the wellbeing of couples.
How to Cite
2. Sibai BM. Prevention of preeclampsia: a big disappointment. American journal of obstetrics and gynecology. 1998;179(5):1275-8.
3. Haghighi L, Hashemi N, Moradi Y, Barzegar N, Najmi Z. The Association Between Menarche Age and First Offspring Sex Ratio. Shiraz E-Medical Journal. 2016;17(1).
4. Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care. Deutsches Ärzteblatt International. 2009;106(45):733.
5. Haghighi L, Nohesara S, Moradi Y, Rashidi M, Moridi M. Psychological Disorders in Women with Spontaneous Preterm Delivery. Shiraz E-Medical Journal. 2016;17(10).
6. Lisonkova S, Joseph K. Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease. American journal of obstetrics and gynecology. 2013;209(6):544. e1-. e12.
7. Nordqvist M, Jacobsson B, Brantsæter A-L, Myhre R, Nilsson S, Sengpiel V. Timing of probiotic milk consumption during pregnancy and effects on the incidence of preeclampsia and preterm delivery: a prospective observational cohort study in Norway. BMJ open. 2018;8(1):e018021.
8. Smith GN, Walker M, Tessier JL, Millar KG. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. American journal of obstetrics and gynecology. 1997;177(2):455-8.
9. Brown MA, Lindheimer MD, de Swiet M, Assche AV, Moutquin J-M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Taylor & Francis; 2001.
10. Moser M. Working group report on high blood pressure in pregnancy. The Journal of Clinical Hypertension. 2001;3(2):75-88.
11. Pham T, Steele J, Stayboldt C, Chan L, Benirschke K. Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: a report of 11 new cases and a review of the literature. American journal of clinical pathology. 2006;126(1):67-78.
12. Chandiramani M, Shennan A. Hypertensive disorders of pregnancy: a UK-based perspective. Current opinion in obstetrics and gynecology. 2008;20(2):96-101.
13. Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. The Journal of Maternal-Fetal & Neonatal Medicine. 2008;21(5):279-87.
14. Mehdizadeh Kashi A, Moradi Y, Chaichian S, Najmi Z, Mansori K, Salehin F, et al. Application of the World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF) to patients with endometriosis. Obstetrics & gynecology science. 2018;61(5):598-604.
15. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstetrics & Gynecology. 2008;112(2):359-72.
16. Grotegut CA. Prevention of preeclampsia. The Journal of clinical investigation. 2016;126(12):4396-8.
17. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J-M. Pre-eclampsia: pathophysiology, diagnosis, and management. Vascular health and risk management. 2011;7:467.
18. FTDLER J, SMITH V, SWIET M. A randomized study comparing timolol and methyldopa in hospital treatment of puerperal hypertension. BJOG: An International Journal of Obstetrics & Gynaecology. 1982;89(12):1031-4.
19. Hoorsan H, Majd HA, Chaichian S, Mehdizadehkashi A, Hoorsan R, Akhlaqghdoust M, et al. Maternal Anthropometric Characteristics and Adverse Pregnancy Outcomes in Iranian Women: A Confirmation Analysis. Archives of Iranian Medicine (AIM). 2018;21(2).
20. Belfort MA, Anthony J, Saade GR, Allen Jr JC. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. New England Journal of Medicine. 2003;348(4):304-11.
21. Meibodi MR, Mossayebi E, Najmi Z, Moradi Y. Normal labor curve is affected by fetus gender: A cohort study. Medical journal of the Islamic Republic of Iran. 2017;31:93.
22. Ascarelli MH, Johnson V, McCreary H, Cushman J, May WL, Martin JN. Postpartum preeclampsia management with furosemide: a randomized clinical trial. Obstetrics & Gynecology. 2005;105(1):29-33.
23. Firoz T, Magee L, MacDonell K, Payne B, Gordon R, Vidler M, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2014;121(10):1210-8.
24. Magee L. Prevention and treatment of postpartum hypertension. 2013.
- Abstract Viewed: 0 times
- PDF Downloaded: 0 times